Literature DB >> 17216083

Inflammation in dry eye.

Michael E Stern1, Stephen C Pflugfelder.   

Abstract

Dry eye is a condition of altered tear composition that results from a diseased or dysfunctional lacrimal functional unit. Evidence suggests that inflammation causes structural alterations and/or functional paralysis of the tear-secreting glands. Changes in tear composition resulting from lacrimal dysfunction, increased evaporation and/or poor clearance have pro-inflammatory effects on the ocular surface. This inflammation is responsible in part for the irritation symptoms, ocular surface epithelial disease, and altered corneal epithelial barrier function in dry eye. Anti-inflammatory therapies for dry eye target one or more of the inflammatory mediators/pathways that have been identified in dry eye.

Entities:  

Year:  2004        PMID: 17216083     DOI: 10.1016/s1542-0124(12)70148-9

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  67 in total

Review 1.  [The dry eye. Current concepts on classification, diagnostics, and pathogenesis].

Authors:  C Jacobi; T Dietrich; C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

2.  Defensins and other antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

3.  Antibody protein array analysis of the tear film cytokines.

Authors:  Shimin Li; Robert Sack; Trinka Vijmasi; Sonal Sathe; Ann Beaton; David Quigley; Marianne Gallup; Nancy A McNamara
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 4.  [Meibomian glands. Part II: physiology, characteristics, distribution and function of meibomian oil].

Authors:  E Knop; N Knop; F Schirra
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

5.  The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.

Authors:  N Yokoi; H Kato; S Kinoshita
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

Review 6.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 7.  [Ophthalmological complications in Sjögren's syndrome].

Authors:  C Jacobi; C Cursiefen
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 8.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

9.  Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.

Authors:  Sabrina Viau; Marie-Annick Maire; Bruno Pasquis; Stéphane Grégoire; Cynthia Fourgeux; Niyazi Acar; Lionel Bretillon; Catherine P Creuzot-Garcher; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-03-21       Impact factor: 3.117

10.  Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model.

Authors:  Lei Zhu; Jikui Shen; Cheng Zhang; Choul Yong Park; Sahar Kohanim; Margaret Yew; John S Parker; Roy S Chuck
Journal:  Mol Vis       Date:  2009-01-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.